Avidity Partners Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,221,555
| Closed | -$5.11M | – | 95 |
|
|
2024
Q1 | $5.11M | Sell |
1,221,555
-133,445
| -10% | -$558K | 0.16% | 73 |
|
|
2023
Q4 | $4.5M | Buy |
1,355,000
+256,500
| +23% | +$852K | 0.16% | 65 |
|
|
2023
Q3 | $2.2M | Sell |
1,098,500
-12,400
| -1% | -$24.8K | 0.09% | 81 |
|
|
2023
Q2 | $3.51M | Sell |
1,110,900
-157,200
| -12% | -$497K | 0.12% | 85 |
|
|
2023
Q1 | $4.4M | Sell |
1,268,100
-35,500
| -3% | -$123K | 0.15% | 73 |
|
|
2022
Q4 | $6.69M | Hold |
1,303,600
| – | – | 0.14% | 64 |
|
|
2022
Q3 | $12.9M | Buy |
1,303,600
+438,600
| +51% | +$4.34M | 0.26% | 64 |
|
|
2022
Q2 | $7.27M | Hold |
865,000
| – | – | 0.17% | 54 |
|
|
2022
Q1 | $10.9M | Buy |
865,000
+13,478
| +2% | +$170K | 0.23% | 59 |
|
|
2021
Q4 | $13.5M | Buy |
851,522
+112,253
| +15% | +$1.78M | 0.29% | 60 |
|
|
2021
Q3 | $18.6M | Sell |
739,269
-264,253
| -26% | -$6.65M | 0.41% | 54 |
|
|
2021
Q2 | $29.4M | Buy |
+1,003,522
| New | +$29.4M | 0.8% | 45 |
|